Miyano-Kurosaki N, Nakashima H, Ichiyama K, Inazawa K, Tabata H, Tanabe H, Ohnishi K, Mizusawa H, Ohshiro Y, Yamamoto N
Department of Microbiology, Tokyo Medical and Dental University, Japan.
Microbiol Immunol. 1994;38(10):813-8. doi: 10.1111/j.1348-0421.1994.tb01863.x.
A subclonal cl.1-14 cell was established from a monocytic cell line U937 by a limiting dilution method. The anti-HIV-1 activity of some antiviral compounds was evaluated in HIV-1-infected cl.1-14 cells. The results demonstrated that although AZT was a potent inhibitor of HIV-1 replication in cl.1-14 cells, its 50% effective concentration (EC50) values was 80 times higher than that in HIV-1 infected MT-4 cells; the EC50 of AZT was 0.16 microM and 0.002 microM in cl.1-14 and MT-4 cells, respectively. In contrast, the anti-HIV-1 activity of ddA, ddI and ddC in cl.1-14 cells was comparable to that in MT-4 cells. The antiviral activity of nevirapine, dextran sulfate, curdlan sulfate and T22 did not differ significantly between the cl.1-14 and MT-4 cells. The antiviral activity of several compounds in the HIV-1-infected cl.1-14 cells was similar to that in the HIV-1JR-FL-infected human peripheral macrophages. Our results suggest that cl.1-14 cell cultures are very useful for estimating antiviral activity and more advantageous than the use of peripheral blood macrophages.
通过有限稀释法从单核细胞系U937中建立了一个亚克隆cl.1-14细胞。在感染HIV-1的cl.1-14细胞中评估了一些抗病毒化合物的抗HIV-1活性。结果表明,虽然齐多夫定(AZT)是cl.1-14细胞中HIV-1复制的有效抑制剂,但其50%有效浓度(EC50)值比感染HIV-1的MT-4细胞高80倍;AZT在cl.1-14细胞和MT-4细胞中的EC50分别为0.16微摩尔和0.002微摩尔。相比之下,双脱氧腺苷(ddA)、双脱氧肌苷(ddI)和双脱氧胞苷(ddC)在cl.1-14细胞中的抗HIV-1活性与在MT-4细胞中的相当。奈韦拉平、硫酸葡聚糖、硫酸凝胶多糖和T22在cl.1-14细胞和MT-4细胞之间的抗病毒活性没有显著差异。几种化合物在感染HIV-1的cl.1-14细胞中的抗病毒活性与在感染HIV-1JR-FL的人外周巨噬细胞中的相似。我们的结果表明,cl.1-14细胞培养物对于评估抗病毒活性非常有用,并且比使用外周血巨噬细胞更具优势。